What Is 10x Genomics, Inc. (TXG) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, 10x Genomics, Inc.'s intrinsic value is estimated at $11.94, suggesting the stock is overvalued at its current price of $41.77. With 13 out of 13 models flagging downside (-71.4% average return), the market may be pricing in unsustainable growth. The most optimistic model, PWERM, places fair value at $36.32 (-13.0%), while ML-RIV — the most conservative — estimates $2.99 (-92.8%). This +79.8% gap reflects genuine analytical uncertainty about 10x Genomics, Inc.'s intrinsic worth. Among models with highest confidence, Markov DDM lean bearish — adding weight to the bearish side of the thesis.
What Do the Models Say About TXG?
13 of 13 models are currently active for TXG. All 13 active models suggest the stock trades above fair value. The Bayesian DCF estimates TXG's intrinsic value at $3.96, implying -90.5% downside from the current price. See which stocks rank higher →
How Does TXG Rank in Laboratory Analytical Instruments?
Among 21 Laboratory Analytical Instruments stocks, TXG ranks #4 by Quality of Company score. CirclFi's QOC score of 8.2/10 evaluates 32 fundamental signals. A score of 8.2 places TXG in the top tier.
10x Genomics, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is TXG a Value Trap?
CirclFi's Value Trap algorithm assigns TXG a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for 10x Genomics, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, 10x Genomics, Inc.'s fundamental quality profile registers 8.2/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +79.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every TXG valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across TXG's 13 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad